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Abstract 
Background:  Abnormal chloride levels are commonly observed in critically ill patients, but their clinical relevance 
remains a matter of debate. We examined the association between abnormal chloremia and ICU and hospital mortal-
ity. To further refine findings and integrate them into the ongoing discussion on the detrimental effects of chloride-
rich solutions, the impact of strong ion difference (SID) on the same end points was assessed.
Methods: Retrospective cohort study in an academic tertiary intensive care unit on 8830 adult patients who stayed 
at least 24 h in the ICU was carried out. Patients admitted after elective cardiac surgery were treated as a separate 
subgroup (n = 2350). Analyses were performed using multivariable logistic regression. All statistical models were 
extensively adjusted for confounders, including comorbidity, admission diagnosis, other electrolytes and acid–base 
parameters.
Results: Severe hyperchloremia (>110 mmol/L), but not low (SID) was significantly associated with increased mortal-
ity in the ICU (odds ratio vs. normochloremia 1.81; 95 % CI 1.32–2.50; p < 0.001) and the hospital (odds ratio 1.49; 95 % 
CI 1.14–1.96; p = 0.003). Hyperchloremia and low (SID) were encountered in the majority of patients admitted after 
cardiac surgery (in 86.9 and 47.2 %, respectively), but were not negatively associated with mortality.
Conclusions: In the ICU, hyperchloremia at admission was associated with negative outcome. On the other hand, 
decreased strong ion difference did not have an impact on mortality, precluding a simple extrapolation of these 
findings to the ongoing discussion on the detrimental effects of chloride-rich solutions. This notion is fueled by the 
finding that hyperchloremia after cardiac surgery, frequently encountered and probably fluid-induced, did not seem 
to be deleterious.
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Background
Chloride is the electrolyte with the highest concentration 
in human plasma after sodium, yet its clinical importance 
is a subject of debate. Despite the high prevalence of 
abnormal chloride levels in the intensive care unit (ICU), 
research on the possible detrimental effects is scarce. 
Hyperchloremia has been shown to be negatively associ-
ated with mortality or kidney failure in certain subgroups 
of patients [1–3], although it is difficult to prove that it 
is an independent factor contributing to outcome rather 
than a mere marker of specific conditions or severity of 
illness [4, 5]. The fact that also hypochloremia has been 
linked to adverse outcomes in postoperative patients in a 
number of small-scale studies may point in this direction 
[6, 7]. Ignoring other electrolytes and acid–base param-
eters by considering chloride in isolation could be part of 
the problem.
Much of the interest is fueled by the fact that hyper-
chloremia can be induced by the intravenous (IV) admin-
istration of the widely used and economically attractive 
NaCl 0.9  % that contains chloride in a non-physio-
logically high amount [8–11]. There is a possibility to 
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discern hyperchloremia caused by intravenous fluid use 
from many other causes by considering the relationship 
between sodium and chloride rather than treating the lat-
ter as a separate entity. The physicochemical approach 
introduced by the late Peter Stewart argues that the dif-
ference between strong cations and anions, by definition 
fully dissociated in human plasma, is one of the three 
independent determinants of pH [12]. This entity, termed 
strong ion difference or (SID), is reduced when hyper-
chloremia exists without an equal increase in sodium, 
e.g., after the intravenous administration of NaCl 0.9 %. 
Knowledge of the clinical impact of (SID) could contrib-
ute to the complex debate on the use of balanced solu-
tions whose purpose is to prevent hyperchloremia and/or 
metabolic acidosis caused by a reduction in (SID). At this 
moment, despite being a well-known and independent 
cause of metabolic acidosis, the relevance of a decreased 
(SID) is doubted [13, 14].
The goal of our study was to analyze the clinical impact 
of abnormal chloremia and (SID) on the first day of 
admission in patients who stayed on a tertiary ICU for 
at least 24  h while taking other influential parameters 
into consideration. We assessed the link with mortality 
both on the ICU and in the hospital. Since this type of 
research could play a role in the ongoing debate on intra-
venous fluid therapy, we purposefully chose to include 
all patients regardless of the reason for their admission 
instead of preselecting subgroups of patients or diseases. 
The main aim of the study was to test the hypothesis that 
hyperchloremia, but also low (SID) are associated with 
negative outcomes.
Methods
Study design, study population and exclusion criteria
We conducted a large-scale retrospective cohort study in 
the 45-bed tertiary ICU at the Antwerp University Hos-
pital, Belgium. The study was reviewed and approved 
by the hospital’s institutional review board (Number 
14/9/88). Since all data were fully de-identified, the 
necessity of obtaining informed consent was waived. We 
collected data on every adult patient (over 16  years of 
age) staying on our ICU for at least 24 h between Octo-
ber 2007 and December 2014. Patients referred from 
another ICU and those receiving renal replacement ther-
apy on their first day of admission were excluded. 10,165 
patients were found eligible for the study (Additional 
file 1: Figure S1). We decided to divide the study popu-
lation into two subgroups, one general ICU population, 
excluding those that underwent elective cardiac surgery, 
and a second including only the latter, as hyperchlo-
remia after this type of surgery is common and probably 
fluid-induced.
Data collection
All data were retrieved from the patient data man-
agement system (Metavision, iMDsoft, Düsseldorf, 
Germany). Demographic data included age, gender, 
Simplified Acute Physiology Score as marker of disease 
severity (SAPS-3) [15], admission type (medical, elec-
tive surgery, emergency surgery including trauma), an 
extensive comorbidity profile and the reason for admis-
sion, divided into 8 medical and 8 surgical categories 
(Additional file  2: Table S2). We also collected data on 
renal function by assessing the RIFLE score based on cre-
atinine level [16]. Because this score can be troubled by 
methodological difficulties, e.g., the incomplete availabil-
ity of baseline creatinine, we also calculated the RIFLE 
score based on urine production using an automated 
search for the 6- and 12-h time frame during which the 
smallest amount of urine was produced on the first day 
of admission [16]. Both scores were used separately in the 
models due to the much higher sensitivity of the urine-
based score.
As regards laboratory data, we used only data from 
each patient’s first day of admission for statistical analy-
sis. Since we were interested in chloride level, at least 
one measurement had to be taken during the first day. If 
multiple measurements were available, the highest value 
was used. Other variables included plasma biochemistry 
data (sodium, potassium, albumin, phosphate, calcium, 
magnesium) and arterial blood gas analysis (pH, pCO2, 
lactate). We only included laboratory data that had been 
taken within a certain time from the referenced chloride 
value: 1  h for sodium, potassium and blood gas param-
eters, and 24  h for albumin, phosphate, calcium and 
magnesium, although in the majority of cases all meas-
urements were performed on the same sample.
To calculate the physicochemical acid–base param-
eters, we used generally accepted formulas and defined 
apparent SID as follows: SIDa = [Na+] + [K+] + [Ca++] 
+ [Mg++] − [Cl−] (all values by convention in mEq/L) [12]. 
Since lactate is fully ionized in the pH range of 6–8, it also 
acts as a strong anion. We decided, however, to exclude 
lactate from the calculation of SIDa because we wished to 
specifically investigate the impact of the electrolytes. The 
inclusion of lactate could have led to ambiguous conclu-
sions considering its well-established role as a marker of 
poor clinical outcome [17]. Effective SID was defined as 
the electrical charge attributed to the routinely measured 
weak anions and calculated as follows: SIDe = bicarbo-
nate  +  albumin charge  +  phosphate charge (all values 
in mEq/L), where bicarbonate  =  0.0301*pCO2*10pH−6.1, 
albumin charge  =  [albumin] in g/L*(pH*0.123–0.631) 
and phosphate charge  =  [phosphate] in mmol/
L*(pH*0.309–0.469) [18, 19]. Strong ion gap (SIG), the 
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sum of routinely unmeasured anions, was defined as 
SIG = SIDa − lactate − SIDe.
Arterial blood gases were analyzed on a point-of-care 
Rapidlab 1265 (Siemens Laboratory Diagnostics, Beersel, 
Belgium). Biochemistry analyses were performed using 
direct potentiometry (Vitros 950, Johnson & Johnson, 
Ortho Clinical Diagnostics, Beerse, Belgium) until April 
2010, after which the central laboratory changed to indi-
rect potentiometry (Dimension Vista 1500, Siemens Lab-
oratory Diagnostics, Beersel, Belgium). To match samples 
taken before and after this transition, Passing-Bablok 
regression equations were applied to the measurements 
taken before April 2010. To exclude residual confounding 
[20, 21] due to this transition, we also added the poten-
tiometry type as a covariate in the statistical models 
and double-checked all conclusions using analyses with 
point-of-care data that were not influenced by a change 
in measurement technique (Additional file  3: Table S3, 
Additional file 4: Table S4).
Statistical analysis and end points
Statistical analyses were performed using STATA 14 
(StataCorp LP, Texas, USA). End points were mortality in 
the ICU within 30 days of admission and hospital mortal-
ity. In the latter case, if a patient was admitted more than 
once, we kept only the last admission for analysis. Means 
were reported ± standard deviations (SD) and confidence 
intervals (CI) at the 95 % level. Patients missing any of the 
covariates were excluded from analysis (Additional file 1: 
Figure S1).
Before constructing each of the statistical models, 
we performed a visual inspection of the predictor–
response relationship between the covariates of interest 
and the outcome variable using locally weighted scatter 
plot smoothing (lowess) [22]. If the shape of the curve 
suggested a nonlinear relationship and thus a detrimen-
tal effect on the end point for both low and high val-
ues, covariates were categorized. We decided to divide 
chloride levels into four categories based on the normal 
range for chloride in our institution: normochloremia 
(98–107 mmol/L), hypochloremia (<98 mmol/L), mod-
erate hyperchloremia (107–110  mmol/L) and severe 
hyperchloremia (>110  mmol/L). We divided hyper-
chloremia into two categories because we observed 
that the mean chloride level in our population 
(107.3 ±  5.5  mmol/L) was at the high end of our nor-
mal range for chloride. In addition, a chloride level of 
>110  mmol/L is accepted in the literature as clinically 
relevant [1, 2]. Because a commonly accepted range of 
(SID) is lacking in the literature and SIDa was normally 
distributed in our population, we opted for cutoff points 
based on the range of one standard deviation around 
the mean value (42.9 ± 3.6): “low SIDa” < 41.1 mEq/L, 
“intermediate SIDa” 41.1–44.7  mEq/L and “high 
SIDa”  >  44.7  mEq/L. We avoided the term “normal 
SIDa” as a decreased (SID) can be the result of an ade-
quate metabolic compensation process.
Since the outcome variables were binary, we used 
multivariable logistic regression. We first constructed 
multivariable models with chloride and SIDa alone, to 
separate osmolality effects (where both sodium and chlo-
ride change in the same direction) from chloride load/
acid–base effects and then tested covariates that are 
known to be associated with the outcome parameter. We 
only kept covariates that considerably improved model 
fit, as assessed by the −2 log likelihood and formal tests 
of equality of the area under the receiver operating char-
acteristic curves (ROC). Covariates that are known to 
potentially influence the covariates of interest (e.g., heart 
failure treated with diuretics, renal failure, albumin level, 
chronic obstructive pulmonary disease and other chronic 
changes in pCO2 can affect chloride level and SIDa) 
were forced into the models regardless of their statisti-
cal impact. For each variable, the odds ratio (OR) was 
calculated with its 95  % CI. To ensure a correct model 
specification, we assessed the quadratic form of the lin-
ear predictor. All models passed the Hosmer–Lemeshow 
goodness-of-fit test. Because of the close relationship 
between some variables, variance inflation factors were 
used to identify collinear independent variables and 
reported with every model. Statistical significance was 
set at a p value of less than 0.05 (two-sided) for all tests.
Results
Demographic data, clinical outcomes and biochemi-
cal values of the study population in the different 
admission types are summarized in Table  1. Mean 
chloride level was 107.3  ±  5.5  mmol/L and mean SID 
42.9 ±  3.6  mEq/L. Table  2 provides the patients’ char-
acteristics of the general ICU population according to 
chloride category. Remarkably, in an unadjusted analy-
sis, patients already suffering from acute kidney injury 
during their first day of admission did not seem to expe-
rience more hyperchloremia than those without. The 
results of the regression models in the general ICU pop-
ulation (n =  6480) are presented in Table  3. There was 
a significant association between severe, but not mod-
erate hyperchloremia and 30-day ICU mortality, with 
an 81  % increase in the odds of death versus normo-
chloremia (p < 0.001). We visualized this model by plot-
ting the relationship between the probability of death 
and SAPS-3 score for different categories of chloremia 
(Fig.  1). This effect was independent of hypernatremia, 
that was encountered notably less frequently than hyper-
chloremia (8.5 vs. 41.1 %). There was no significant asso-
ciation between low SIDa and mortality. Analyses with 
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hospital mortality as the outcome parameter showed 
similar results (odds ratio of severe hyperchloremia ver-
sus normochloremia 1.46; 95 % CI 1.14–1.96; p = 0.003), 
although also hypochloremia and high SIDa showed 
a negative association. We also constructed a model in 
patients with hyperchloremia (>107  mmol/L), treating 
chloride level as a continuous variable, resulting in an 
OR of death of 1.06 per 1 mmol/L rise in chloride (95 % 
CI 1.01–1.11; p  =  0.02). Finally, the possibility exists 
that not every fluid-related dyschloremia is reflected by 
assessing only the highest chloride level of the first day 
of admission, as this could neglect an additional resusci-
tation effort after the assessment. Therefore, we also per-
formed an additional sensitivity analysis by constructing 
a statistical model using the highest chloride level and 
lowest SIDa of the first 2 days of admission. The results 
are presented in Additional file 5: Table S5 and confirm 
the main analysis.   
The subgroup of patients that underwent elective car-
diac surgery consisted of 2350 patients. Of note, the 
majority of patients experienced some form of hyper-
chloremia (n  =  2042, 86.9  %) and chloride level was 
significantly higher than in the general study popula-
tion (111.3  ±  3.4 vs. 106.1  ±  5.5  mmol/L; p  <  0.001), 
while SIDa was lower (41.2 ± 3.0 vs. 43.4 ± 3.6 mmol/L; 
p  <  0.001) (Table  1). Table  4 presents the results of 
the regression models. Neither hyperchloremia nor 
SIDa was significantly associated with 30-day mortal-
ity. With regard to hospital mortality, moderate (OR 
0.43; p  =  0.01) and severe hyperchloremia (OR 0.37; 
p = 0.004) were significantly associated with a decreased 
odds of death.
Table 1 Clinical characteristics, outcome data and biochemistry values on day 1 of admission
SAPS Simplified Acute Physiology Score, COPD chronic obstructive pulmonary disease, SIDa apparent strong ion difference, SIDe effective strong ion difference, SIG 
strong ion gap






Elective surgery Emergency surgery 
and trauma
n = 2109 (20.7 %)Cardiac Other
n = 2357 (23.2 %) n = 2194 (21.6 %)
Demographic data
 Female (%) 3861 (38.0 %) 1369 (39.1 %) 754 (32.0 %) 914 (41.7 %) 824 (39.1 %)
 Age (mean in years ± SD) 62.7 ± 15.3 63.0 ± 15.0 68.7 ± 10.7 60.1 ± 14.4 58.1 ± 17.0
 SAPS-3 (mean ± SD) 49.5 ± 16.2 61.3 ± 14.5 40.5 ± 8.9 36.8 ± 10.9 53.1 ± 14.1
Comorbidities [n (%)]
 Chronic kidney disease 1317 (12.9 %) 600 (17.1 %) 297 (12.6 %) 187 (8.5 %) 233 (11.1 %)
 Heart failure 2931 (28.8 %) 963 (27.19 %) 1392 (59.1 %) 217 (9.9 %) 369 (17.5 %)
 COPD 1120 (11.0 %) 490 (14.0 %) 228 (9.7 %) 243 (11.1 %) 159 (7.5 %)
 Diabetes mellitus 1743 (17.2 %) 671 (19.1 %) 489 (20.8 %) 290 (13.2 %) 293 (13.9 %)
 Liver cirrhosis 348 (3.4 %) 202 (5.8 %) 10 (0.4 %) 63 (2.9 %) 73 (3.5 %)
 Malignancy 440 (4.3 %) 96 (2.7 %) 11 (0.5 %) 283 (12.9 %) 50 (2.37 %)
Outcome [n (%)]
 30-day ICU mortality 929 (9.1 %) 622 (17.8 %) 54 (2.3 %) 44 (2.0 %) 209 (9.9 %)
 Hospital mortalitya 1661 (19.7 %) 1061 (37.6 %) 99 (4.5 %) 173 (10.0 %) 327 (19.1 %)
Covariates of interest on day of admission (mean ± SD)
 Chloride (mmol/L) 107.3 ± 5.5 104.6 ± 6.0 111.3 ± 3.4 107.6 ± 3.9 107.1 ± 5.3
 SIDa (mEq/L) 42.9 ± 3.6 44.3 ± 4.0 41.2 ± 3.0 42.4 ± 2.9 43.1 ± 3.4
Biochemistry and physicochemical covariates on day of admission (mean ± SD)
 Sodium (mmol/L) 140.1 ± 4.9 138.8 ± 5.4 142.3 ± 3.7 139.9 ± 3.7 140.1 ± 5.2
 Lactate (mmol/L) 2.4 ± 2.1 2.4 ± 2.5 2.8 ± 1.6 1.7 ± 1.1 2.5 ± 2.4
 Albumin (g/L) 27.2 ± 7.0 28.5 ± 6.9 23.0 ± 5.0 28.5 ± 6.1 28.2 ± 8.0
 SIDa incl. lactate (mEq/L) 40.6 ± 3.9 42.0 ± 4.3 38.4 ± 2.9 40.7 ± 3.0 40.7 ± 3.6
 SIDe (mEq/L) 33.7 ± 4.9 34.8 ± 5.8 30.6 ± 3.3 34.7 ± 3.5 34.0 ± 4.6
 SIG (mEq/L) 6.9 ± 3.5 7.2 ± 3.8 7.8 ± 2.9 5.9 ± 3.0 6.6 ± 3.7
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Discussion
We found a significant and consistent association 
between severe hyperchloremia and mortality in a large 
ICU population, confirming on a broader scale previ-
ous findings after non-cardiac surgery and sepsis [1, 2]. 
The inclusion of every patient staying at least 24  h in 
the ICU and thus the widest possible range of diagno-
ses and patient profiles extends the scope of the conclu-
sions to include critically ill patients in general. As far as 
we know, this is the first study in a broad ICU population 
including the largest number of patients ever analyzed 
in this regard. The challenging question whether hyper-
chloremia has a causal role or is merely a consequence 
of certain conditions remains an issue that cannot be 
fully elucidated using our study design. The most obvi-
ous example of this chicken and egg situation can be 
found in kidney injury. While hyperchloremia could 
be a consequence of renal failure, it was also found to 
induce vasoconstriction of the afferent arteriole leading 
to the renal glomerulus and to reduce renal blood flow 
Table 2 Patients’ characteristics according to chloride category
COPD chronic obstructive pulmonary disease, SIDa apparent strong ion difference (excl. lactate)
a If more than one ICU admission, only data on the last admission were used
General ICU population  
(excl. cardiac surgery)




n = 6480 n = 434 n = 3382 n = 1456 n = 1206
Patient characteristics
Age (mean ± SD) 63.0 ± 14.9 62.0 ± 15.7 60.1 ± 15.8 59.3 ± 15.9
SAPS-3 (mean ± SD) 59.2 ± 14.6 51.8 ± 17.1 48.2 ± 17.1 52.8 ± 17.7
Mechanical ventilation on day 2 25 (5.8 %) 149 (4.4 %) 83 (5.7 %) 87 (7.2 %)
Comorbidities
 COPD 113 (26.0 %) 427 (12.6 %) 140 (9.6 %) 74 (6.1 %)
 Heart failure 140 (32.3 %) 699 (20.7 %) 193 (13.3 %) 150 (12.4 %)
 Chronic kidney disease 90 (20.7 %) 422 (12.5 %) 170 (11.7 %) 144 (11.9 %)
Outcome
30-day mortality 434 (16.4 %) 3382 (10.2 %) 1456 (8.5 %) 1208 (14.6 %)
Hospital mortality (n = 5184a) 329 (43.8 %) 2707 (24.3 %) 1188 (18.4 %) 960 (29 %)
Acute kidney injury [n (%)]
 Creatinine-based RIFLE score
  None (81.0 %) 300 (5.7 %) 2747 (52.3 %) 1237 (23.6 %) 967 (18.4 %)
  Risk (9.3 %) 57 (9.4 %) 296 (48.9 %) 132 (21.8 %) 120 (19.8 %)
  Injury (5.7 %) 39 (10.6 %) 193 (52.6 %) 53 (14.4 %) 82 (22.3 %)
  Failure (4.0 %) 38 (14.8 %) 146 (56.8 %) 34 (13.2 %) 39 (15.2 %)
 Urine-based RIFLE score
  None (14.4 %) 70 (7.5 %) 479 (51.34 %) 199 (21.3 %) 185 (19.8 %)
  Risk (48.7 %) 195 (6.2 %) 1624 (51.5 %) 715 (22.7 %) 618 (19.6 %)
  Injury (35.3 %) 144 (6.3 %) 1217 (53.2 %) 530 (23.2 %) 398 (17.4 %)
  Failure (1.6 %) 25 (23.6 %) 62 (58.5 %) 12 (11.3 %) 7 (6.6 %)
Biochemistry and physicochemical covariates on day of admission
 pCO2
  Low (<35 mmHg) 96 (22.1 %) 773 (22.9 %) 359 (24.7 %) 372 (30.8 %)
  Normal 186 (42.9 %) 1850 (54.7 %) 849 (58.3 %) 664 (55.0 %)
  High (>45 mmHg) 152 (35.0 %) 759 (22.4 %) 248 (17.0 %) 172 (14.2 %)
 Sodium (mmol/L) 132.3 ± 5.6 137.9 ± 3.2 141.1 ± 2.9 144.6 ± 4.5
 SIDa (excl. lactate) (mEq/L) 47.7 ± 4.6 43.9 ± 3.1 42.3 ± 2.7 41.1 ± 3.5
 Lactate (mmol/L) 3.1 ± 3.1 2.8 ± 2.6 2.7 ± 2.3 3.3 ± 2.8
 Strong ion gap (SIG) (mEq/L) 6.9 ± 4.7 6.6 ± 3.3 6.4 ± 3.3 6.8 ± 3.8
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Table 3 Logistic regression models in the total ICU population excluding patients admitted after elective cardiac surgery
SIDa apparent strong ion difference (excl. lactate), ROC receiver under operating characteristics curve, VIF variance inflation factor
a Confounders adjusted for in the model: sodium (high vs. normal*, low vs. normal*), SAPS-3, admission reason, RIFLEcrea*, RIFLEurine, lactate, heart failure*, COPD*, 
pCO2* (low, normal, high), albumin, SIG, potentiometry type* (*p > 0.05)
b Confounders adjusted for in the model: sodium (high vs. normal*, low vs. normal*), SAPS-3, admission reason, RIFLEcrea, RIFLEurine, lactate, heart failure, COPD, 
pCO2* (low, normal, high), albumin, SIG*, potentiometry type (*p > 0.05)
Outcome: 30-day mortalitya (n = 6480) Outcome: hospital mortalityb (n = 5184)
n % outcome (%) Odds ratio (95 % CI) 
versus normochlo-
remia





Normochloremia 3382 10.2 2707 24.3
Hypochloremia 434 16.4 1.02 (0.71–1.48) 0.91 329 43.8 1.55 (1.13–2.13) 0.007
Moderate  
hyperchloremia
1456 8.5 1.16 (0.88–1.51) 0.30 1188 18.4 0.96 (0.77–1.20) 0.72
Severe hyperchloremia 1208 14.6 1.81 (1.32–2.50) <0.001 960 29.0 1.49 (1.14–1.96) 0.003
n % outcome (%) Odds ratio (95 % CI)  
versus intermediate 
SIDa





Intermediate SIDa 2982 9.6 2382 20.5
Low SIDa 1598 9.4 0.89 (0.68–1.16) 0.40 1260 21.5 0.94 (0.70–1.15) 0.60
High SIDa 1900 14.6 1.05 (0.83–1.32) 0.71 1542 34.9 1.35 (1.11–1.65) 0.002
Area under ROC 86.7 % Area under ROC 83.5 %
Maximal VIF 2.26 Maximal VIF 2.39








































Chloride <98 mmol/L 98-107 mmol/L 107-110 mmol/L >110 mmol/L
Fig. 1 Probability of 30-day mortality per chloride category based on the logistic regression model in Table 2. Simulation using a lactate level of 
2 mEq/L, an admission diagnosis associated with a high risk of death (e.g., sepsis; Additional file 2: Table S2), no comorbidities and a normal sodium 
level
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velocity and cortical perfusion [23, 24]. Our extensive 
dataset allowed for a precise and granular profiling of the 
included patients and their illness, and we also adjusted 
all statistical models for sodium level and kidney injury at 
admission, using two separate calculations of the RIFLE 
score (creatinine and diuresis). Also, the lack of a clearly 
increased prevalence of hyperchloremia in patients with 
acute kidney injury (Table 2) could be a step toward the 
answer to this question.
It could be tempting to add these findings to the grow-
ing evidence of the deleterious effect of chloride-rich solu-
tions. However, a unilateral view on hyperchloremia, with 
its broad causal range, could lead to premature conclu-
sions. We addressed this issue twofold. First, we assessed 
SIDa in conjunction with chloremia as it is unaltered by the 
change of sodium and chloride in the same direction and 
thus a more selective indicator of hyperchloremia induced 
by intravenous fluid use. SIDa is a difficult parameter to 
handle, as it can itself be the result of a physiological or 
compensatory process [25–27]. We therefore constructed 
statistical models that included relevant parameters (SIG, 
lactate, albumin, pCO2) and comorbidities. Second, we 
performed all analyses on a large subgroup of patients 
admitted after elective cardiac surgery of which we could 
assume most of the postoperative electrolyte disturbances 
were caused by intraoperative fluid manipulations. None 
of our statistical models showed a significant relation-
ship between low SIDa and outcome. Additionally, in the 
cardiac surgery subgroup, hyperchloremia was not harm-
ful and was even associated with a significant reduction 
of hospital mortality, although it is possible that hypoal-
buminemia/hypernatremia-induced alkalosis in this 
subgroup mitigates hyperchloremia-induced metabolic 
acidosis. We believe this finding should urge clinicians to 
adopt a cautious approach in drawing conclusions in the 
debate on chloride-rich solutions based on findings con-
sidering only hyperchloremia. In different experiments, 
detrimental renal effects could be observed after a fast-
administered, highly dosed amount of chloride-rich flu-
ids [24, 28, 29]. Our data, reflecting real-life use and thus 
a broad range of fluid strategies for different clinical rea-
sons, do not disprove the existence of this phenomenon, as 
we lacked a detailed fluid profile in our dataset. Also, our 
approach principally took fluid-induced metabolic acido-
sis into account, whereas the total amount of administered 
chloride could be an equally relevant culprit, as was shown 
in certain studies [30, 31], although one could expect a 
major chloride load to be reflected in chloride level.
Apart from the retrospective design, the possibility of 
still unmeasured confounding and the rather arbitrary 
Table 4 Logistic regression models on the subgroup admitted after elective cardiac surgery
SIDa apparent strong ion difference (excl. lactate), ROC Receiver under Operating Characteristics Curve, VIF variance inflation factor
a Confounders adjusted for in the model: sodium (high vs. normal, low vs. normal*), SAPS-3, RIFLEcrea, lactate, heart failure*, COPD*, pCO2* (low, normal, high), 
albumin*, SIG, potentiometry type (*p > 0.05). RIFLEurine omitted because of collinearity
b Confounders adjusted for in the model: sodium (high vs. normal, low vs. normal*), SAPS-3, RIFLEcrea, lactate, heart failure*, COPD, pCO2* (low, normal, high), 
albumin*, SIG, potentiometry type (*p > 0.05). RIFLEurine omitted because of collinearity
Outcome: 30-day mortalitya (n = 2350) Outcome: hospital mortalityb (n = 2156)
n % outcome (%) Odds ratio (95 % CI) 
versus normochloremia




 Normochloremia 287 5.6 246 13.4
 Hypochloremia 21 23.8 3.49 (0.62–19.62) 0.16 15 40.0 1.45 (0.30–7.18) 0.64
 Moderate  
hyperchloremia
596 3.0 0.63 (0.26–1.54) 0.31 550 5.1 0.43 (0.22–0.83) 0.01
 Severe hyperchloremia 1446 2.7 0.57 (0.22–1.44) 0.23 1345 4.5 0.37 (0.18–0.73) 0.004
n % outcome (%) Odds ratio (95 % CI)  
versus mean SID




 Intermediate SIDa 941 2.6 873 5.2
 Low SIDa 1110 2.0 1.46 (0.68–3.11) 0.34 1015 4.1 1.13 (0.63–2.03) 0.68
 High SIDa 229 10.7 0.85 (0.39–1.83) 0.67 268 14.9 0.71 (0.38–1.31) 0.27
Area under ROC 88.3 % Area under ROC 83.9 %
Maximal VIF 3.53 Maximal VIF 3.58
Tolerance 0.66 Tolerance 0.66
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cutoff for low SIDa, we regard our inability to decou-
ple chloride level from pre-admission fluid therapy as 
the most important limitation of our study. It is plausible 
that a patient who develops hyperchloremia in the ICU 
after large volume resuscitation in the operating theater 
or emergency room will have a higher chance of mortal-
ity than a patient that is normochloremic without the need 
for a comparable resuscitation effort. Hyperchloremia 
could be a mere reflection of the amount of resuscitation 
fluids, itself being a marker of severity of shock and/or 
fluid overload and thus mortality. This limitation applies 
in the same way to the other recently published studies on 
the detrimental effects of hyperchloremia. In a retrospec-
tive cohort study, hyperchloremia at 72  h of ICU stay in 
septic patients was found to be associated with hospital 
mortality [2]. The lack of data on intravenous fluid admin-
istration during ICU stay could reduce the conclusion to 
the message that the amount of these fluids, rather than 
their chloride content, was associated with mortality. Like-
wise, in the abovementioned cohort study in postoperative 
patients, even careful propensity matching could prob-
ably not resolve the question whether the amount or the 
chloride content of intraoperative fluid was responsible 
for the observed mortality increase [1]. Even research on 
the effect of chloride load itself is unable to fully decouple 
chloride level from the administered fluid volume [30–32].
Conclusions
In a general intensive care population, after careful con-
trolling for confounders, hyperchloremia was signifi-
cantly associated with increased 30-day ICU and hospital 
mortality. A low strong ion difference on the other hand, 
was not found to be linked with negative outcome, pre-
cluding a simplistic extrapolation of our and other find-
ings on hyperchloremia to the ongoing discussion on the 
detrimental effects of chloride-rich solutions.
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